Akash Maniam: Brilliantly designed I-SPY2 trial

Akash Maniam, Medical Oncologis at Portsmouth Hospitals University NHS Trust, shared on LinekdIn:

“Brilliantly designed I-SPY2 trial – adaptive neoadjuvant treatments for early breast cancer, stratified by receptor status, DNA repair deficiency and immunogenicity and tailored according to predicted response.

The ADC/IO synergy continues to grow and this trial could really set the platform for personalised de-escalation and intensification approaches.

Great abstract at ESMO24.”

Source: Akash Maniam/LinkedIn